| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4c0cf6d13d2539db84c38b6e28882c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ddc142ff7e240eda9059f11aad2723f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca7c109e96ea002b896c90befc5cf334 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095 |
| filingDate |
2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dbe313544060a920f3cc464cc5bc1ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dd7f2f73312d00f03ea2c73cd6bbd94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25837c24c737289f7828ab61597dceac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81e604ad52dda7348ff1c7ba86ed6952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d60a10f5fb5d76b1b579a120d174f44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8af0570b7e0c0807447bc09350b58a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9684f827eed62da6587b170552eb4a99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84ef24e0acb291ad4e87a5d7dfa70bf4 |
| publicationDate |
2020-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PL-426879-A1 |
| titleOfInvention |
The combination of isothiocyanates with organic selenium compounds in drug carriers as a new pharmaceutical agent with anti-cancer activity |
| abstract |
The subject of the application is a pharmaceutical formulation with antitumor properties containing at least one isothiocyanate and selol as an isothiocyanate enhancer for use in the treatment of cancer, wherein at least one isothiocyanate and selol are contained in a lipid carrier. |
| priorityDate |
2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |